Metabolic Complications
Metabolic complications of
parenteral nutrition include alterations in fluid and electrolyte balance,
acid-base balance, glucose control, dyslipidemia, refeeding syndrome, vitamin
and mineral status, hepatobiliary and renal function, and bone diseases. The
following text will explore each type of complication, their clinical features
and strategies for prevention and treatment. Appendix
A summarizes metabolic complications of TPN, including prevention
strategies, signs and symptoms of complications, and treatment strategies.
Fluid and Sodium Imbalance
Fluid imbalance can occur early in
TPN. Prevention strategies against dehydration and fluid overload should
consider the patient’s risk profile for fluid intolerance and formula volume.
Fluid intake and output should be monitored on a daily basis along with daily
weights to identify fluid imbalances. Most complete nutrition prescriptions
will include between 1.5 to 3 liters of volume. A typical calorie infusion will
provide approximately 1 calorie/mL of fluid. In some cases, volume intolerance
may require alterations in this ratio. Fluid restrictions, in patients with
pulmonary, renal, or hepatic failure, may require a more concentrated
formulation. For instance, fluid overload can occur in patients with cardiac
disease and a predisposition to congestive heart failure) and those with renal
disease. In these cases, the rate of infusion can be decreased and the
concentration of the formula may be increased according to tolerance. Fat
emulsions can be used to provide adequate calories in high-risk patients who may
require volume restrictions.
Fluid imbalances can affect the
balance of electrolytes, which can also occur early in the course of TPN. Lab
values should be monitored often in the early stages of TPN until stabilized, at
which time routine monitoring can be implemented. Fluid overload in excessive
hypotonic formulations can lead to hyponatremia, and fluid restriction may
result in hypernatremia. Adrenal insufficiency, nephritis, syndrome of
inappropriate antidiuretic hormone, cirrhosis with ascites, and congestive heart
failure can cause fluid imbalance and hyponatremia. Clinical symptoms include
confusion, hypotension, lethargy, and in some cases seizures. Balanced fluids
and, in some cases, use of diuretics will help to overcome these alterations. If
sodium intake is inadequate, sodium could be increased in the parenteral
nutrition formulation.
Though rare, hypernatremia can
occur when there are excessive water losses or excessive sodium intake. Clinical
symptoms are typically increases in thirst, loss of skin turgor and “tenting”,
and irritability. Oral fluid intake may be important to reduce the effect of
dehydration and hypernatremia. Sodium content of the formulation can also be
reduced.
Refeeding Syndrome and
Carbohydrate-Dependent Nutrients
This multifactoral complication
involves imbalances of fluids, electrolytes, and other micronutrients can occur
at the beginning of a course of TPN. High-risk populations include patients with
a history of alcoholism and anorexia nervosa or other causes of marasmus.
Aggressive refeeding, especially
with high-dextrose concentrations, can trigger refeeding syndrome in the
malnourished patient as anabolic processes quickly shift nutrients into and out
of body compartments. Markers of refeeding syndrome include low levels of the
three carbohydrate dependent minerals: magnesium, phosphorus, and potassium.
Other associated findings may include hemolytic anemia, cardiac arrhythmias,
respiratory distress, and tetany. The mortality rate can be high and prompt
recognition and treatment is essential to survival and recovery. Refeeding
syndrome may require the discontinuation of TPN. Once carbohydrate is increased,
care should be taken to proportionately increase the carbohydrate-dependent
minerals (potassium, magnesium, and phosphorus). Limiting sodium to 20 mEq or
less per day may also lower the risk for refeeding syndrome.